The disclosure of Dnel levels is not provided for under current law. The deriving of such values is costly and the information should not be accessible to competitors without careful consideration (Article 115).
Amendement déposé par Holger Krahmer et Jorgo Chatzimarkakis Amendement 355 Article 116, paragraphe 1, point a) a) la ou les marques commerciales de la substance; supprimé